Clinical Trial

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Sanofi's Genetic Disorder Drug Shows Promise in Gaucher Trial, Stumbles in Fabry Study

Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.

Feb 2, 2026

Business

Perspective Therapeutics Surges on Promising Cancer Trial Data, But Valuation Gap Raises Questions

Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.

Feb 2, 2026

Business

Definium Therapeutics Bolsters Board with Commercial Veteran Roger Adsett Ahead of Pivotal Trials

Biotech firm Definium Therapeutics appoints seasoned commercial executive Roger Adsett to its board, signaling a strategic shift towards commercialization as key late-stage trial data approaches.

Jan 31, 2026

Business

Immunocore Gains Analyst Backing as Late-Stage Trials Loom

Immunocore Holdings (NASDAQ: IMCR) has drawn renewed bullish sentiment from analysts at H.C. Wainwright and UBS, who highlight the stock's potential as key Phase 3 trial data for its cancer immunotherapies approaches later this decade.

Jan 30, 2026

Business

Genmab Shares Face Target Cut After EPKINLY Trial Misses Survival Goal, But Analysts Keep Faith

H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.

Jan 30, 2026

Business

Quince Therapeutics Plummets After Late-Stage Trial of A-T Therapy Fails to Hit Targets

Quince Therapeutics' lead candidate, eDSP, has failed to meet primary and secondary endpoints in its pivotal Phase III NEAT trial for the rare neurological disorder Ataxia-Telangiectasia (A-T), triggering a catastrophic drop in the company's share price.

Feb 2, 2026

Business

Industrial Sector Outperforms: One Stock to Watch, Two to Approach with Caution

While the industrial sector has surged ahead of the broader market, not all companies are equally positioned for sustainable growth. We analyze one defense contractor with strong tailwinds and two manufacturers where valuation concerns loom large.

Feb 2, 2026

Business

Industrial Sector Surges, But Stock Picking Is Key: One to Watch, Two to Approach with Caution

The industrial sector has outperformed the broader market, buoyed by regulatory shifts. However, not all companies are equally positioned. We analyze one stock with a durable edge and two facing potential headwinds.

Feb 2, 2026

Business

Industrial Sector Outperforms, But These 3 Stocks Flash Caution Signals

While the industrial sector has surged ahead of the broader market, not all companies are positioned to weather an economic downturn. We examine three industrial stocks where valuation and business model concerns suggest investors should proceed with caution.

Feb 2, 2026

Business

Industrial Sector Outperforms: Two Stocks Poised for Growth, One Faces Headwinds

While often operating behind the scenes, industrial companies are the engine of the U.S. economy. Bolstered by a favorable interest rate environment, the sector has surged 18.8% in the last six months, significantly outpacing the S&P 500. We analyze two firms with durable competitive edges and one that may be losing momentum.

Feb 2, 2026

Business

Aalberts N.V. Shares Rally: Is the Dutch Industrial Play Still Undervalued?

Aalberts N.V. (AMS:AALB), a mid-cap specialist in industrial technology, has seen a significant price surge on the ENXTAM, prompting analysts to revisit its valuation and growth trajectory amidst market volatility.

Feb 2, 2026

Business

Singapore's Green Flight Ambition Takes Off: Google, Airlines Join Landmark SAF Procurement Trial

A consortium of nine major corporations, including Google and Singapore Airlines, is launching a voluntary trial for centralized sustainable aviation fuel (SAF) procurement. This pilot, led by the newly formed SAFCo, is a critical step ahead of Singapore's pioneering green levy on departing flights set for October, aiming to refine systems for a 1% SAF usage target.

Feb 2, 2026

Business

Illinois Tool Works Q4 Earnings Preview: Can the Industrial Giant Beat Expectations?

As Illinois Tool Works prepares to report its fourth-quarter results, investors are weighing steady growth forecasts against a history of revenue misses. The report comes amid a mixed performance for the industrial machinery sector.

Feb 2, 2026

Business

Grainger Earnings Preview: Industrial Distributor Faces Growth Test Amid Sector Momentum

W.W. Grainger (GWW) reports quarterly earnings Tuesday morning, with investors watching for signs of sustained growth against a backdrop of mixed industrial sector performance and recent stock gains.

Feb 2, 2026

Business

AMETEK Earnings Preview: Can the Industrial Tech Leader Sustain Its Momentum?

As AMETEK prepares to report its quarterly results, investors are watching to see if the electronics manufacturer can maintain its streak of strong performance amid a mixed landscape for industrial equipment firms.

Feb 2, 2026

Business

Insiders Hold the Reins: CB Industrial Product's Leadership Stakes Its Future on Company Performance

A commanding 66% insider ownership at CB Industrial Product Holding Berhad (KLSE:CBIP) aligns management's fortunes directly with shareholders, raising questions about governance and future direction in Malaysia's industrial sector.

Feb 2, 2026

Business

Terreno's Miami Landfill Transformation: A Blueprint for Industrial Real Estate Value?

Terreno Realty Corporation has completed a key industrial facility in Hialeah, Florida, part of a larger strategy to redevelop a former landfill into a premium logistics hub. The move highlights the firm's focus on coastal infill markets and raises questions about execution risks and valuation as the project scales up.

Jan 31, 2026

Business

Microchip Bolsters Automotive and Industrial Tech with New MCU and Touchscreen Controllers

Microchip Technology expands its embedded systems portfolio with the launch of the PIC32CM PL10 microcontroller family and an enhanced maXTouch M1 touchscreen line, targeting growing demand in automotive displays and industrial automation.

Jan 31, 2026

Business

Palantir Expands Industrial and Sovereign AI Footprint with HD Hyundai Partnership and EMEA Data Center Role

Palantir Technologies strengthens its position in industrial digital transformation and secure AI infrastructure through a broadened partnership with South Korea's HD Hyundai and a new role in developing sovereign AI data centers across Europe, the Middle East, and Africa.

Jan 31, 2026